mesalamine has been researched along with Nausea in 4 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 38-year-old Caucasian man with a medical history significant for inflammatory bowel disease (IBD) and mesalamine use presented to the emergency department with stabbing, pleuritic, substernal chest pain over the previous 2 days." | 7.81 | Cardiac MRI-confirmed mesalamine-induced myocarditis. ( Baker, WL; Elliott, K; Parker, MW; Saulsberry, WJ, 2015) |
| "A 38-year-old Caucasian man with a medical history significant for inflammatory bowel disease (IBD) and mesalamine use presented to the emergency department with stabbing, pleuritic, substernal chest pain over the previous 2 days." | 3.81 | Cardiac MRI-confirmed mesalamine-induced myocarditis. ( Baker, WL; Elliott, K; Parker, MW; Saulsberry, WJ, 2015) |
| "A randomized, 2-way, crossover study was conducted in 30 volunteers to compare the pharmacokinetic profile of a new once-daily dosing regimen of mesalazine (1 x 4 g/d) with the current twice-daily dosage (2 x 2 g/d) used in many European countries." | 2.73 | Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers. ( Gandia, P; Houin, G; Idier, I, 2007) |
| "Nausea was a frequent problem in patients taking SP." | 1.27 | A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. ( Astbury, C; Bird, HA; Hill, J; Le Gallez, P; Neumann, VC; Taggart, AJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, WL | 1 |
| Saulsberry, WJ | 1 |
| Elliott, K | 1 |
| Parker, MW | 1 |
| Gandia, P | 1 |
| Idier, I | 1 |
| Houin, G | 1 |
| Neumann, VC | 1 |
| Taggart, AJ | 1 |
| Le Gallez, P | 1 |
| Astbury, C | 1 |
| Hill, J | 1 |
| Bird, HA | 1 |
1 trial available for mesalamine and Nausea
| Article | Year |
|---|---|
Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers.
Topics: Acetylglucosaminidase; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroi | 2007 |
3 other studies available for mesalamine and Nausea
| Article | Year |
|---|---|
Cardiac MRI-confirmed mesalamine-induced myocarditis.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chest Pain; Dyspnea; Follow | 2015 |
Oral balsalazide (Colazal) for ulcerative colitis.
Topics: Abdominal Pain; Administration, Oral; Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; | 2001 |
A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
Topics: Adult; Aged; Aminosalicylic Acids; Arthritis, Rheumatoid; Female; Humans; Male; Mesalamine; Middle A | 1986 |